Corporate News
Result of AGM
15 September 2021
p>Omega (AIM: ODX), the medical diagnostics company focused on Global Health (CD4 and COVID-19) and Health and Nutrition, announces that all resolutions were duly passed at the Annual General Meeting held earlier today.
The results are set out below:
| Resolution | For | Against | Discretion to Chairman | Withheld | Total |
|---|---|---|---|---|---|
| 1 | 9,374,684 | 23,021 | 32,985 | 88,420 | 9,519,110 |
| 2 | 9,421,626 | 59,735 | 32,985 | 4,764 | 9,519,110 |
| 3 | 5,015,063 | 4,138,825 | 32,985 | 332,237 | 9,519,110 |
| 4 | 5,095,359 | 358,971 | 32,985 | 4,031,795 | 9,519,110 |
| 5 | 8,514,388 | 963,219 | 32,985 | 8,518 | 9,519,110 |
| 6 | 8,430,095 | 1,047,954 | 32,985 | 8,076 | 9,519,110 |
Contacts:
| Omega Diagnostics Group PLC | www.omegadiagnostics.com |
| Colin King, Chief Executive | via Walbrook PR |
| Chris Lea, Chief Financial Officer | |
| finnCap Ltd | Tel: 020 7220 0500 |
| Geoff Nash/Edward Whiley (Corporate Finance) | |
| Alice Lane/ Charlotte Sutcliffe (ECM) | |
| Walbrook PR Limited | Tel: 020 7933 8780 or [email protected] |
| Paul McManus | Mob: 07980 541 893 |
| Lianne Cawthorne | Mob: 07584 391 303 |
Latest Share Price
Investor News
-
21 November 2024
Interim Report -
15 November 2024
Notice of Results and Investor Presentation